Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
University of Health Sciences Antigua · Amager Hospital · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
392
total citations
- FWCI
- 79.77
- Percentile
- 100%
- References
- 47
Citations per year
Authors
269Topics & keywords
Topics
Keywords
- Cascade
- Medicine
- Virology
- Environmental health
- Internal medicine
- Engineering
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- NSNational Science FoundationAward: 2020-2023
- ALAbbott Laboratories
- AAmgen
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- WHWorld Health OrganizationAward: COVID-19
- GSGilead SciencesAward: COVID-19
- APAlexion Pharmaceuticals
- APAlnylam Pharmaceuticals
- AEAsociación Española para el Estudio del Hígado
- CBCSL Behring
- BSBoston Scientific Corporation
- IIndivior
- AGAustralian Government
- IPIntercept Pharmaceuticals
- SFStiftung für Leberkrankheiten
- CACanadian Association for the Study of the Liver
- ECEuropean Centre for Disease Prevention and Control
- SNSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungAward: 2020-2023
- EEisai
- NNNovo Nordisk
- SGState Government of Victoria
- APAstellas Pharma
- SShionogi
- APAngelini Pharma
- EAEuropean Association for the Study of the Liver
- SOSwedish Orphan Biovitrum
- IIpsen
- AOAOP Orphan
- NSNational Science and Technology Council
- NNorgine
- NINational Institutes of HealthAwards: 2020-2023, COVID-19, K08AI148607
- GGenentech
- AAllergan
- PAPan American Health Organization
- NCNational Cancer Institute
- NINational Institute of Allergy and Infectious DiseasesAward: COVID-19
- JPJanssen Pharmaceuticals
- CCilag